You are here

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2024

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020052
Mar 2020002
Apr 2020026
May 2020050
Jun 202002380
Jul 2020060
Aug 2020040
Sep 20200100
Oct 2020020
Nov 2020010
Dec 2020030
Jan 2021073
Feb 2021012
Mar 2021030
Apr 2021020
May 2021071
Jun 2021040
Jul 2021010
Sep 2021033
Oct 2021011
Nov 2021083
Dec 2021072
Jan 2022070
Feb 2022030
Mar 2022031
Apr 20220124
May 20220221
Jun 20220192
Jul 20220102
Aug 2022091
Sep 20220152
Oct 20220150
Nov 20220109
Dec 2022082
Jan 2023040
Feb 20230340
Mar 2023062
Apr 2023010
Jun 2023010
Jul 2023012
Aug 2023041
Sep 2023030
Oct 2023012
Nov 2023031
Dec 2023011
Jan 2024061
Feb 20240111
Mar 20240735
Apr 2024085
May 2024042
Jun 20240251
Jul 20240202
Aug 2024041
Sep 20240125
Total0613112